About Cervel
Cervel is a Healthcare company based in Redwood City (United States) founded in 2008, and was acquired by Rio Grande Neurosciences in October 2015. Treatment-resistant depression is addressed through non-invasive transcranial magnetic stimulation. Cervel has raised $23.6 million across 6 funding rounds from investors including East West Bank, D. E. Shaw Group and Rio Grande Neurosciences. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its competitors include Freespira, Motif neurotech and Neuronetics; 3 of its 3 listed competitors have raised funding.
Company details
Cervel Neurotech was founded in 2008 as a privately held medical device company based in Redwood City, United States. Focus is placed on non-invasive deep brain neuromodulation for treatment-resistant depression within the healthcare sector. Repetitive transcranial magnetic stimulation (rTMS) is utilized, where magnetic fields are applied to induce electrical currents in targeted brain areas, thereby modulating neural function. Operations center on device development and clinical applications for psychiatric conditions.
- Headquarters Redwood City, United States
- Stage Acquired
- SectorsHealthcare
- Website cervel.com
- Social LinkedIn
- Acquired by Rio Grande Neurosciences (Oct 2015)
- Total Equity Funding$23.6M (USD)
in 6 rounds
- Latest Funding Round$1M (USD), Series C
Nov 2014
- InvestorsEast West Bank
& 3 more
- Acquired byRio Grande Neurosciences
(Oct 2015)
Funding Insights of Cervel
Cervel has successfully raised a total of $23.6M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $1 million completed in November 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $23.6M
- Total Rounds 6
- Last Round Series C — $1M
- First Round $1M
(Nov 2009)
- Investors Count 3
All 6 funding rounds of Cervel with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2014 | $1M | Series C | – | – | – |
| Apr 2013 | $14.1M | Series C | – | D. E. Shaw Group, Aberdare Ventures | – |
| Apr 2013 | Debt – Conventional | – | – | ||
| Jan 2013 | $3.3M | Debt – Conventional | – | – | – |
| Feb 2010 | $7.5M | Series A | – | – | – |
| Nov 2009 | $1M | Seed | – | – | – |
4 investors in total: 4 institutional.
Investors in Cervel
Cervel has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include East West Bank, D. E. Shaw Group and Rio Grande Neurosciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US Life-Sciences sectors are targeted for investment by Aberdare Ventures. | aberdare.com | San Francisco, United States | ||
Commercial banking services are offered to individuals and businesses. | 1973 | eastwestbank.com | Los Angeles, United States | |
Multinational investment management services are provided globally. | 1988 | deshaw.com | New York, United States | |
Non-invasive brain stimulation therapies for CNS disorders are developed. | 2011 | riograndeneurosciences.com | San Francisco, United States |
Investor details for Cervel
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cervel
4 dated milestones of Cervel across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Cervel is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Series C, of $1.0M.
- Exit Acquired by Rio Grande Neurosciences.
Competitors of Cervel
Cervel has 3 listed competitors in our database, 3 of them funded. They include Freespira, Motif neurotech and Neuronetics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| freespira.com | 2008 | Danville, United States | $48.94M | 25 | Panic disorders are treated via breathing device and mobile app. | |
| motifneuro.tech | 2022 | Houston, United States | $18.75M | Minimally invasive bioelectronics are developed for mental health disorders. | ||
| neuronetics.com | 2001 | Malvern, United States | $177.8M | 167 | Non-invasive magnetic therapies for psychiatric and neurological disorders are developed. |
Detailed competitors of Cervel
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Health Monitoring & Wearables
3 companies that operate in the same segment as Cervel (Health Monitoring & Wearables) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cervel
Complete news archive for Cervel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cervel
Cervel was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Cervel is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Cervel is a funded company, having raised a total of $23.6M across 6 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Nov 2009.
Cervel Neurotech was founded in 2008 as a privately held medical device company based in Redwood City, United States. Focus is placed on non-invasive deep brain neuromodulation for treatment-resistant depression within the healthcare sector. Repetitive transcranial magnetic stimulation (rTMS) is utilized, where magnetic fields are applied to induce electrical currents in targeted brain areas, thereby modulating neural function. Operations center on device development and clinical applications for psychiatric conditions.
Cervel's top competitors include Motif neurotech, Neuronetics and Freespira.
Cervel has 4 investors. Key investors include East West Bank, D. E. Shaw Group, Rio Grande Neurosciences, and Aberdare Ventures.
Yes. Cervel was acquired by Rio Grande Neurosciences in October 2015.